Journals / Klinik Tıp Bilimleri / 2018 / Cilt: 6 - Sayı: 4

I am Considering Metabolic Surgery For Patient whois Obese and has Type 2 Diabetes

Obezitesi ve Tip 2 Diyabeti Olan Hastada Metabolik Cerrahi Düşünüyorum

Pages
28–31
Publication Date
2018-04-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally it has been documented that metabolic surgery not only achieved glycemic control butalso result in decrease in cardiovascular risk with improvement in triglyseride and HDL-cholesterol levels as well as decrase in systolic and diastolic blood pressure.It is clear that metabolic surgery has and will have an important part in the treatmentalgorithyms of type 2 diabetes with expanding indications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractObesity and obesity related diseases endanger modern society as an unpreventable pandemic.
📊
Key Findings & Data:Treatment of obesity related diseases suchas type 2 diabetes, hypertension, fatty liver and dyslipidemia have expanded the targets of treatment and metabolic results have become as important as loosing excess weight.
💡
Conclusion & Impact:Additionally it has been documented that metabolic surgery not only achieved glycemic control butalso result in decrease in cardiovascular risk with improvement in triglyseride and HDL-cholesterol levels as well as decrase in systolic and diastolic blood pressure.It is clear that metabolic surgery has and will have an important part in the treatmentalgorithyms of type 2 diabetes with expanding indications.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Metabolik cerrahi · Tip 2 diyabet · Obezite

Abstract

AbstractObesity and obesity related diseases endanger modern society as an unpreventable pandemic. Bariatric surgery has been performed with great success in the treatment of morbid obesity for many years. Treatment of obesity related diseases suchas type 2 diabetes, hypertension, fatty liver and dyslipidemia have expanded the targets of treatment and metabolic results have become as important as loosing excess weight. It has been observed that effective glycemic control could be achieved before substantial weight loss and both experimental and clinical studies suggested thatgastrointestinal tract manipulation could be used for the treatment of diabetes. In randomized trials metabolic surgical treatment has been shown to be superior to intense medical treatment for glysemic control in diabetic patients. Additionally it has been documented that metabolic surgery not only achieved glycemic control butalso result in decrease in cardiovascular risk with improvement in triglyseride and HDL-cholesterol levels as well as decrase in systolic and diastolic blood pressure.It is clear that metabolic surgery has and will have an important part in the treatmentalgorithyms of type 2 diabetes with expanding indications.

Özet

ÖzObezite ve obezitenin tetiklediği hastalıklar önünü alamadığımız bir salgın olarak modern toplumu tehdit etmektedir. Bariatrik cerrahi yöntemler obezite tedavisinde uzun süredir etkin bir tedavi yöntemi olarak kullanılmaktadır. Tip 2 diyabet, hipertansiyon, yağlı karaciğer, dislipidemi gibi yandaş hastalıkların tedavisi, obez bireylerde planlanan cerrahi tedavilerin hedefini genişletmiş ve tedavinin metabolik olumlu sonuçları en az kilo vermek kadar önem kazanmıştır. Cerrahi sonrası henüz belirgin kilo vermeye yeni başlamışken bile glisemik kontrolün etkin bir şekilde sağlanabildiği anlaşılmış ve gastrointestinal sistem manüpülasyonları ile diyabet tedavisinde başarı sağlanabileceği hem deneysel hem deklinik çalışmalarda gösterilmiştir. Yapılan randomize karşılaştırmalı çalışmalarda diyabet kontrolü için metabolik cerrahi tedavi en iyi medikal tedaviye üstünbulunmuştur. Ayrıca metabolik cerrahi yöntemler ile elde edilen sonuçlar diyabet kontrolü ile sınırlı kalmamış ve trigliserid ve HDL düzeylerinde iyileşme, sis-tolik ve diastolik kan basıncında azalma ile beraber kardiyovasküler risk azalma-sı sağlanabilmiştir. Tip 2 diyabet tedavisinde, cerrahi yöntemlerin giderek geniş-leyen endikasyon kriterleri ile tedavi algoritmalarının önemli bir parçası olmasıkaçınılmaz gözükmektedir.

🔖

Cite This Article

CİNGİ, P. D. A. (2018). I am Considering Metabolic Surgery For Patient whois Obese and has Type 2 Diabetes. Klinik Tıp Bilimleri, Cilt: 6 - Sayı: 4, 28–31. https://ajindex.com/articles/838230

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kaynaklar 1.Komlos, John and Brabec, Marek, The Trend of BMI Va-lues Among US Adults (March 2010). CESifo Working Pa-per Series No. 2987. Available at SSRN: https://ssrn.com/abstract=1573500 2.World Health Organization
  2. 2017, Global health obser-vatory (http://www.who.int/gho/en/) 3.Printz C. Extreme obesity may shorten life expectancy upto 14 years. Cancer. 2014
  3. Angrisani L, Santonicola A, Iovino P, Formisano G, Buch-wald H, Scopinaro N. Bariatric Surgery Worldwide2013. Obes Surg. 2015
  4. Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres A,Weiner R, et al
  5. International Federation for Surgery ofObesity and Metabolic Disorders-European Chapter(IFSO-EC)
  6. European Association for the Study of Obe-sity (EASO)
  7. European Association for the Study of Obe-sity Obesity Management Task Force (EASO OMTF). In-terdisciplinary European guidelines on metabolic and ba-riatric surgery. Obes Surg. 2014
  8. Cohen RV, Shikora S, Petry T, Caravatto PP, Le Roux CW.The Diabetes Surgery Summit II Guidelines: a Disease-Based Clinical Recommendation. Obes Surg. 2016
  9. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG,Zimmet PZ, et al.
  10. Delegates of the 2nd Diabetes SurgerySummit. Metabolic Surgery in the Treatment Algorithm for ype 2 Diabetes: A Joint Statement by International Dia-betes Organizations. Diabetes Care. 2016
  11. Rubino F, Marescaux J. Effect of duodenaljejunal exclu-sion in a non-obese animal model of type 2 diabetes: anew perspective for an old disease. Ann Surg.2004
  12. 1–11. 9.Breen DM, Rasmussen BA, Kokorovic A, Wang R, Che-ung GW, Lam TK. Jejunal nutrient sensing is required forduodenal-jejunal bypass surgery to rapidly lower gluco-se concentrations in uncontrolled diabetes. Nat Med.2012
  13. 950–5. 10.Thaler JP, Cummings DE. Minireview: hormonal and me-tabolic mechanisms of diabetes remission after gastroin-testinal surgery. Endocrinology. 2009
  14. 2518–25. 11.Madsbad S, Dirksen C, Holst JJ. Mechanisms of chan-ges in glu- cose metabolism and bodyweight after bari-atric surgery. Lancet Diabetes Endocrinol. 2014
  15. 152–64. 12.Schauer PR, Bhatt DL, Kirwan JP, Wolski K, BrethauerSA, Navaneethan SD, et al. Bariatric surgery versus in-tensive medical therapy for diabetes—3-year outcomes.N Engl J Med. 2014
  16. 2002–13. 13.Ikramuddin S, Korner J, Lee W-J, Connett JE, Inabnet WB,Billington CJ, et al. Roux-en-Y gastric bypass vs inten-sive medical management for the control of type 2 dia-betes, hypertension, and hyp